======= CPNE1 ======= == Gene Information == * **Official Symbol**: CPNE1 * **Official Name**: copine 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8904|8904]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q99829|Q99829]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CPNE1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CPNE1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604205|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Calcium-dependent phospholipid-binding protein that plays a role in calcium-mediated intracellular processes (PubMed:14674885). Involved in the TNF-alpha receptor signaling pathway in a calcium-dependent manner (PubMed:14674885). Exhibits calcium-dependent phospholipid binding properties (PubMed:9430674, PubMed:19539605). Plays a role in neuronal progenitor cell differentiation; induces neurite outgrowth via a AKT-dependent signaling cascade and calcium-independent manner (PubMed:23263657, PubMed:25450385). May recruit target proteins to the cell membrane in a calcium-dependent manner (PubMed:12522145). May function in membrane trafficking (PubMed:9430674). Involved in TNF-alpha- induced NF-kappa-B transcriptional repression by inducing endoprotease processing of the transcription factor NF-kappa-B p65/RELA subunit (PubMed:18212740). Also induces endoprotease processing of NF-kappa-B p50/NFKB1, p52/NFKB2, RELB and REL (PubMed:18212740). {ECO:0000269|PubMed:12522145, ECO:0000269|PubMed:14674885, ECO:0000269|PubMed:18212740, ECO:0000269|PubMed:19539605, ECO:0000269|PubMed:23263657, ECO:0000269|PubMed:25450385, ECO:0000269|PubMed:9430674}. |C2| |Copine| |positive regulation of tumor necrosis factor-mediated signaling pathway| |negative regulation of NIK/NF-kappaB signaling| |NF-kappaB binding| |transporter activity| |positive regulation of cytokine-mediated signaling pathway| |negative regulation of DNA binding| |calcium-dependent phospholipid binding| |positive regulation of response to cytokine stimulus| |regulation of tumor necrosis factor-mediated signaling pathway| |azurophil granule membrane| |phosphatidylserine binding| |neuron projection extension| |endopeptidase activity| |cellular response to calcium ion| |developmental cell growth| |cell growth| |regulation of NIK/NF-kappaB signaling| |developmental growth involved in morphogenesis| |regulation of DNA binding| |response to calcium ion| |regulation of cytokine-mediated signaling pathway| |positive regulation of protein kinase B signaling| |negative regulation of binding| |regulation of response to cytokine stimulus| |cellular response to metal ion| |glycerophospholipid biosynthetic process| |cellular response to inorganic substance| |regulation of protein kinase B signaling| |glycerolipid biosynthetic process| |regulation of I-kappaB kinase/NF-kappaB signaling| |nuclear membrane| |phospholipid biosynthetic process| |glycerophospholipid metabolic process| |positive regulation of neuron differentiation| |response to metal ion| |phospholipid metabolic process| |regulation of binding| |glycerolipid metabolic process| |developmental growth| |growth| |positive regulation of neurogenesis| |neuron projection morphogenesis| |plasma membrane bounded cell projection morphogenesis| |neutrophil degranulation| |cell projection morphogenesis| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |negative regulation of intracellular signal transduction| |leukocyte degranulation| |cell part morphogenesis| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |response to inorganic substance| |positive regulation of nervous system development| |organophosphate biosynthetic process| |positive regulation of cell development| |lipid biosynthetic process| |myeloid leukocyte activation| |leukocyte activation involved in immune response| |cell activation involved in immune response| |regulation of neuron differentiation| |neuron projection development| |regulated exocytosis| |calcium ion binding| |cell morphogenesis| |leukocyte mediated immunity| |exocytosis| |neuron development| |regulation of neurogenesis| |cellular component morphogenesis| |protein homodimerization activity| |organophosphate metabolic process| |regulation of nervous system development| |leukocyte activation| |regulation of cell development| |cellular lipid metabolic process| |positive regulation of cell differentiation| |secretion by cell| |neuron differentiation| |positive regulation of intracellular signal transduction| |export from cell| |cell activation| |immune effector process| |plasma membrane bounded cell projection organization| |secretion| |negative regulation of molecular function| |cell projection organization| |lipid metabolic process| |negative regulation of signal transduction| |proteolysis| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of developmental process| |generation of neurons| |negative regulation of response to stimulus| |neurogenesis| |cell development| |positive regulation of signal transduction| |negative regulation of gene expression| |positive regulation of multicellular organismal process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |immune response| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp494|Isoniazid 100μM R08 exp494]]|-2.31| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|-1.85| |[[:results:exp260|ABT-702 0.1μM R06 exp260]]|-1.73| |[[:results:exp298|Sucrose 20000μM R06 exp298]]|-1.71| |[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|1.74| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|1.76| |[[:results:exp538|ZLN024 50μM R08 exp538]]|1.81| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6155 * **Expression level (log2 read counts)**: 6.49 {{:chemogenomics:nalm6 dist.png?nolink |}}